Item 16. Form 10-K Summary

4K characters. Original on sec.gov · Markdown

Item 16. Form 10-K Summary

Not applicable.

SCHEDULE II

AMPHENOL CORPORATION AND SUBSIDIARIES

VALUATION AND QUALIFYING ACCOUNTS

For the years ended December 31, 2019, 2018 and 2017

(Dollars in millions)


	Balance at		Charged to				Balance at
	beginning		cost and		Additions		end of
	of period		expenses		(Deductions)		period
Allowance for doubtful accounts:
Year ended December 31, 2019	$	33.5	$	1.2	$	(1.1)	$	33.6
Year ended December 31, 2018		23.0		13.0		(2.5)		33.5
Year ended December 31, 2017		23.6		1.8		(2.4)		23.0

Valuation allowance on deferred tax assets:
Year ended December 31, 2019	$	34.7	$	0.2	$	0.3	$	35.2
Year ended December 31, 2018		39.6		(3.8)		(1.1)		34.7
Year ended December 31, 2017		37.2		2.5		(0.1)		39.6

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized in the Town of Wallingford, State of Connecticut on the 12th day of February, 2020.


	AMPHENOL CORPORATION


	/s/ R. Adam Norwitt
	R. Adam Norwitt
	President and Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.


Signature	Title	Date


/s/ R. Adam Norwitt	President, Chief Executive Officer and Director	February 12, 2020
R. Adam Norwitt	(Principal Executive Officer)

/s/ Craig A. Lampo	Senior Vice President and Chief Financial Officer	February 12, 2020
Craig A. Lampo	(Principal Financial Officer and Principal Accounting Officer)

/s/ Martin H. Loeffler	Chairman of the Board of Directors	February 12, 2020
Martin H. Loeffler

/s/ Stanley L. Clark	Director	February 12, 2020
Stanley L. Clark

/s/ John D. Craig	Director	February 12, 2020
John D. Craig

/s/ David P. Falck	Director	February 12, 2020
David P. Falck

/s/ Edward G. Jepsen	Director	February 12, 2020
Edward G. Jepsen

/s/ Robert A. Livingston	Director	February 12, 2020
Robert A. Livingston

/s/ Anne Clarke Wolff	Director	February 12, 2020
Anne Clarke Wolff

Previous: Item 15. Exhibits, Financial Statement Schedules